Stayble Therapeutics AB (publ) 4K4.F Stock
Stayble Therapeutics AB (publ) Price Chart
Stayble Therapeutics AB (publ) 4K4.F Financial and Trading Overview
| Stayble Therapeutics AB (publ) stock price | 0.02 EUR |
| Previous Close | 0.2 EUR |
| Open | 0.2 EUR |
| Bid | 0.21 EUR x N/A |
| Ask | 0.24 EUR x N/A |
| Day's Range | 0.2 - 0.2 EUR |
| 52 Week Range | 0.1 - 0.43 EUR |
| Volume | 4.75K EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 7.38M EUR |
| Beta (5Y Monthly) | 1.163529 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4K4.F Valuation Measures
| Enterprise Value | 2.67M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stayble Therapeutics AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.163529 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.43 EUR |
| 52 Week Low | 0.1 EUR |
| 50-Day Moving Average | 0.16 EUR |
| 200-Day Moving Average | 0.22 EUR |
4K4.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 31.72M |
| Float | 12.88M |
| Short Ratio | N/A |
| % Held by Insiders | 29.97% |
| % Held by Institutions | 21.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -47.20% |
| Return on Equity (ttm) | -95.31% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 7.61 EUR |
| Current Ratio (mrq) | 2.538 |
| Book Value Per Share (mrq) | -0.073 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Stayble Therapeutics AB (publ)
| Country | Germany |
| State | N/A |
| City | Gothenburg |
| Address | Arvid Hedvalls Backe 4 |
| ZIP | 411 33 |
| Phone | N/A |
| Website | https://www.staybletherapeutics.se |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Stayble Therapeutics AB (publ) develops injectable treatment for chronic low back pain triggered by disc degeneration. The company develops STA363, a minimally invasive single injection of the drug into the disc that targets chronic low back pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden.
Q&A For Stayble Therapeutics AB (publ) Stock
What is a current 4K4.F stock price?
Stayble Therapeutics AB (publ) 4K4.F stock price today per share is 0.02 EUR.
How to purchase Stayble Therapeutics AB (publ) stock?
You can buy 4K4.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Stayble Therapeutics AB (publ)?
The stock symbol or ticker of Stayble Therapeutics AB (publ) is 4K4.F.
Which industry does the Stayble Therapeutics AB (publ) company belong to?
The Stayble Therapeutics AB (publ) industry is Biotechnology.
How many shares does Stayble Therapeutics AB (publ) have in circulation?
The max supply of Stayble Therapeutics AB (publ) shares is 35.71M.
What is Stayble Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?
Stayble Therapeutics AB (publ) PE Ratio is now.
What was Stayble Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?
Stayble Therapeutics AB (publ) EPS is -0.09 EUR over the trailing 12 months.
Which sector does the Stayble Therapeutics AB (publ) company belong to?
The Stayble Therapeutics AB (publ) sector is Healthcare.